Anti Aging Product | Nu Skin Enterprises Reports Record Fourth-Quarter And 2011 Results
February 8, 2012 – 8:39 am
PROVO, Utah, Feb. 2, 2012 /PRNewswire/ — Nu Skin Enterprises, Inc. (NYSE: NUS – News ) currently voiced record fourth-quarter and annual results. Revenue is to entertain was $495.3 million, a 23 percent alleviation over the previous year. Quarterly income was in a positive way impacted 2 percent by unfamiliar banking fluctuations. Earnings per share is to entertain increased 31 percent to $0.76, compared to $0.58 in the previous year.
The firm reported annual income of $1.74 billion, a 13 percent year-over-year improvement. Annual income was in a positive way impacted 6 percent by unfamiliar banking fluctuations. Earnings per share is to year were $2.38, a 13 percent enlarge over 2010, or $2.69, a 27 percent improvement, when on the contrary non-cash charges of $32.8 million related with a Japan etiquette statute during the year.
“We are exceedingly gratified with our quarterly and 2011 results,” mentioned Truman Hunt, boss and arch senior manager officer. “By all measures, 2011 was a record year. We’re moreover confident that our movement will go on in to 2012 as you hurl out our ultimate product innovations globally. Our ageLOC super-class of anti-aging products continues to be a expansion matter as demonstrated by the tremendously successful limited-time offers of the ageLOC Galvanic Body Spa and ageLOC R2 (R-squared) in the fourth quarter.
“In add-on to the appetite surrounding ageLOC, you are gratified with expansion in the sales force, quite in the Greater China and South Asia/Pacific regions, together with in South Korea.
“Additionally, as you voiced in other let go progressing this morning, formed on our 2011 expansion and burly change sheet, you are raising our quarterly division by 25 percent,” one after another Hunt.
Regional Results
North Asia. Fourth-quarter income in North Middle East grew 13 percent to $204.3 million, compared to $180.6 million is to same time in 2010. Revenue was in a positive way impacted 4 percent by unfamiliar banking fluctuations. Local-currency income increased 49 percent in South Korea, offsetting an 8 percent local-currency reject in Japan. The number of senior manager and active distributors in the zone increased 4 and 3 percent, respectively, compared to the previous year.
Greater China. Revenue in Greater China softened 66 percent to $110.6 million is to quarter, and was in a positive way impacted 3 percent by unfamiliar banking fluctuations. The senior manager distributor tally in the zone increased 47 percent and the number of active distributors softened 21 percent.
Americas. Fourth-quarter income in the Americas increased 25 percent to $76.9 million, compared to $61.4 million is to previous year. Regional results were increased by roughly $13 million of gathering sales to distributors from outward the region. The number of senior manager and active distributors in the zone increased 1 and 3 percent, respectively.
South Asia/Pacific. Revenue in South Asia/Pacific was $65.2 million is to fourth quarter, a 27 percent alleviation over the previous year. Currency negatively impacted results by roughly 1 percent. The region’s fourth-quarter senior manager tally softened 43 percent, whilst the active distributor tally increased 18 percent.
Europe. Fourth-quarter income in Europe was $38.3 million, an 8 percent lessen over the previous year. Results in the zone were negatively impacted roughly 2 percent by unfamiliar banking fluctuations. Executive distributor counts in the zone remained even with the previous year, whilst the number of active distributors softened 2 percent.
Operational Performance
The company’s working border softened to 15.3 percent, compared to 14.7 percent in the previous year. Gross border is to entertain was 83.8 percent, a 150 basement indicate alleviation over the previous year. Selling expenses, as a percent of revenue, were 43.3 percent, compared to 42.1 percent in 2010. The enlarge is attributed to a aloft number of distributors subordinate for promotional sales incentives. General and organizational expenses, as a percent of revenue, were 25.2 percent, a 30 basis-point alleviation over the prior-year period.
The company’s income taxation rate is to entertain was 34.9 percent, compared to 34.3 percent in the previous year. Dividend payments during the entertain were $10.0 million and the firm repurchased $16.1 million of its shares outstanding.
For 2011, increased income and a aloft turn of profitability resulted in money from operations enhancing to $224 million. During the year, the firm paid $37 million in dividends and repurchased roughly $67 million of its stock. The firm finished the year with $291 million in money and stream investments and $137 million of debt.
“We closed out 2011 on a high note and expect other record year in 2012,” mentioned Hunt. “Our first expansion motorist for 2012 will be the universal hurl out of our new ageLOC products. We launched these products in the Americas, North Middle East and Europe regions in January and will go on the hurl outs in the Greater China and South Asia/Pacific regions in the second and third quarters.
“Emerging markets go on to produce burly results with quite splendid expansion in the Greater China and South Asia/Pacific regions. Our initiatives are pushing plain expansion in our distributor force as evidenced by healthy gains in both our active and senior manager distributor numbers, reflecting our convincing business chance and fueling our confidence is to future. Overall, you are gratified with the one after another positive citation of the business and you think that you are on follow to produce other record year in 2012,” resolved Hunt.
“Although you not long ago supposing 2012 guidance, formed upon a plain beginning to this year together with aloft expectations for our informal product launches, you are stepping up our annual income superintendence to $1.81 billion to $1.84 billion,” mentioned Ritch Wood, arch financial officer. “We go on to see banking negatively impacting 2012 income by 1 percent. In addition, you are stepping up our gain superintendence to $2.84 to $2.94 per share. We plan first-quarter income of $437 to $447 million with gain per share in the $0.68 to $0.71 range. We expect banking repercussions to be neutral is to first quarter,” resolved Wood.
The company’s administration will horde a webcast with the investment residents on Feb. 2, 2012, at 11 a.m. (EST). The wishing to access the webcast, together with the financial data presented during the call, can revisit the Investor Relations page on Nu Skin Enterprises’ Web site, . An repository of the webcast will be existing at this same URL by Feb. 17, 2012.
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. demonstrates its tradition of enhancement by its thorough anti-aging product portfolio, eccentric business chance and corporate amicable shortcoming initiatives. The company’s systematic care in both skin care and nourishment has determined Nu Skin as a premier anti-aging company, evidenced in its unique ageLOC scholarship that addresses aging at its source. The company’s anti-aging products underline the new ageLOC apartment of products inclusive the ageLOC R2 (R-squared) nutritive supplement, ageLOC Galvanic Spa System and Galvanic Body Spa, together with the ageLOC Transformation every day skin care system. A universal send selling company, Nu Skin operates in 52 markets worldwide and has more than 850,000 eccentric distributors. Nu Skin is traded on the New York Stock Exchange beneath the pitch “NUS.” More data is existing at .
Please note: This press release, quite the “Outlook” section, contains forward-looking statements inside of the meaning of Section 21E of the Securities Exchange Act of 1934 that act for the company’s stream expectations and beliefs, including, amid other things: (i) management’s positive standpoint is to company; (ii) management’s expectations concerning the company’s initiatives, strategies and new products; and (iii) management’s projections concerning revenue, gain per share, and the repercussions of unfamiliar banking fluctuations. The forward-looking statements and related assumptions engage risks and uncertainties that could result in real results and outcomes to deviate materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not paltry to, the following: (a) any disaster of stream or programmed initiatives or products to produce fascination amid distributors and customers and produce sponsoring and selling actions on a postulated basis; (b) severe mercantile conditions globally; (c) risk of unfamiliar banking fluctuations and the banking interpretation repercussions on our business related with these fluctuations; (d) doubt concerning the repercussions on our business of increased regulatory investigation of the send selling attention in Japan and our efforts to enlarge distributor correspondence efforts in this market; (e) risks related with increased broad inquiries and complaints to consumer insurance agencies in Japan concerning the actions of a few distributors; (f) regulatory risks related with the company’s products, that could restrain the company’s capability to marketplace a product in a marketplace if it is determined to be a medical device in any market, if distributors make without official authorization claims that would result in such products to be personal as drugs, or if the firm is not able to to get hold of vital product registrations in a timely manner; (g) one after another regulatory investigation and investigations in Mainland China, that have from time to time in the past, and could in the future, negatively repercussions the company’s business, inclusive the stop of sales actions in stores, loss of licenses, and the deception of fines; (h) inauspicious promotion related to the company’s business, products, attention or any authorised actions or complaints by distributors or others; (i) any potential or retrospective increases in duties on our products alien in to our markets outward of the United States and any inauspicious results of taxation audits or unfavorable changes to taxation laws in our assorted markets; and (j) one after another aggressive pressures in the company’s markets. The company’s financial opening and the forward-looking statements contained herein are serve competent by a minute deliberation of related risks set onward in the papers filed by the firm with the Securities and Exchange Commission. The forward-looking statements set onward the company’s doctrine as of the date of this release, and the firm assumes no task to refurbish the forward-looking statements contained in this let go to simulate any change solely as compulsory by law.
* Active distributors add elite customers and distributors purchasing products right away from the firm during the quarter.
** Less than 1%
|
|
|
Tags: anti aging product